RNAi expression constructs
US8076471B2 · kind B2 · utility
1Cited by
3References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2006 |
| Grant date | Dec 13, 2011 |
| Priority date | — |
| Expiry date | Apr 15, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24211
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.